|
J Biol Chem, Vol. 274, Issue 4, 2502-2510, January 22, 1999
Aryl Hydrocarbon Receptor Regulation of Ceramide-induced
Apoptosis in Murine Hepatoma 1c1c7 Cells
A FUNCTION INDEPENDENT OF ARYL HYDROCARBON RECEPTOR NUCLEAR
TRANSLOCATOR
John J.
Reiners Jr. and
Russell E.
Clift
From the Institute of Chemical Toxicology, Wayne State University,
Detroit, Michigan 48201
The relationship between aryl hydrocarbon
receptor (AHR) content and susceptibility to apoptosis was examined in
the murine hepatoma 1c1c7 cell line and a series of variants having
different levels of AHR expression. Exposure of 1c1c7 cultures to
N-acetylsphingosine (C2-ceramide) caused a
concentration-dependent inhibition of cell proliferation,
loss of viability, and induction of apoptosis as monitored by analyses
of DNA fragmentation and caspase activation. A variant cell line (Tao)
having ~10% of the AHR content of 1c1c7 cells also arrested
following exposure to C2-ceramide, but did not undergo
apoptosis. Modulation of 1c1c7 and Tao AHR contents by transfection of
Ahr antisense and sense constructs, respectively, confirmed
the relationship between AHR content and susceptibility to
C2-ceramide-induced apoptosis. C2-ceramide also
induced the apoptosis of an AHR-containing cell line lacking the aryl
hydrocarbon receptor nuclear translocator protein. AHR ligands
(i.e. 2,3,7,8-tetrachlorodibenzo-p-dioxin and
-naphthoflavone) neither induced apoptosis nor modulated the
development of apoptosis in C2-ceramide-treated 1c1c7
cultures. AHR content did not affect staurosporine- or
doxorubicin-induced apoptosis. These results suggest the AHR modulates
aspects of ceramide signaling associated with the induction of
apoptosis but not cell cycle arrest, and does so by a mechanism that is independent of its interaction with aryl hydrocarbon receptor nuclear
translocator and exogenous AHR ligands.
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Biswas, S. Srinivasan, H. K. Anandatheerthavarada, and N. G. Avadhani
Dioxin-mediated tumor progression through activation of mitochondria-to-nucleus stress signaling
PNAS,
January 8, 2008;
105(1):
186 - 191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Wu, L. Zhang, M. S. Hoagland, and H. I. Swanson
Lack of the Aryl Hydrocarbon Receptor Leads to Impaired Activation of AKT/Protein Kinase B and Enhanced Sensitivity to Apoptosis Induced via the Intrinsic Pathway
J. Pharmacol. Exp. Ther.,
January 1, 2007;
320(1):
448 - 457.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Caruso, P. A. Mathieu, A. Joiakim, H. Zhang, and J. J. Reiners Jr.
Aryl Hydrocarbon Receptor Modulation of Tumor Necrosis Factor-{alpha}-induced Apoptosis and Lysosomal Disruption in a Hepatoma Model That Is Caspase-8-independent
J. Biol. Chem.,
April 21, 2006;
281(16):
10954 - 10967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pocar, D. Nestler, M. Risch, and B. Fischer
Apoptosis in bovine cumulus-oocyte complexes after exposure to polychlorinated biphenyl mixtures during in vitro maturation
Reproduction,
December 1, 2005;
130(6):
857 - 868.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P Pocar, B Fischer, T Klonisch, and S Hombach-Klonisch
Molecular interactions of the aryl hydrocarbon receptor and its biological and toxicological relevance for reproduction
Reproduction,
April 1, 2005;
129(4):
379 - 389.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-T. Park, K. A. Mitchell, G. Huang, and C. J. Elferink
The Aryl Hydrocarbon Receptor Predisposes Hepatocytes to Fas-Mediated Apoptosis
Mol. Pharmacol.,
March 1, 2005;
67(3):
612 - 622.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Joiakim, P. A. Mathieu, A. A. Elliott, and J. J. Reiners Jr.
Superinduction of CYP1A1 in MCF10A Cultures by Cycloheximide, Anisomycin, and Puromycin: A Process Independent of Effects on Protein Translation and Unrelated to Suppression of Aryl Hydrocarbon Receptor Proteolysis by the Proteasome
Mol. Pharmacol.,
October 1, 2004;
66(4):
936 - 947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Walisser, M. K. Bunger, E. Glover, E. B. Harstad, and C. A. Bradfield
Patent Ductus Venosus and Dioxin Resistance in Mice Harboring a Hypomorphic Arnt Allele
J. Biol. Chem.,
April 16, 2004;
279(16):
16326 - 16331.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Caruso, P. A. Mathieu, A. Joiakim, B. Leeson, D. Kessel, B. F. Sloane, and J. J. Reiners Jr.
Differential Susceptibilities of Murine Hepatoma 1c1c7 and Tao Cells to the Lysosomal Photosensitizer NPe6: Influence of Aryl Hydrocarbon Receptor on Lysosomal Fragility and Protease Contents
Mol. Pharmacol.,
April 1, 2004;
65(4):
1016 - 1028.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. K. Bunger, S. M. Moran, E. Glover, T. L. Thomae, G. P. Lahvis, B. C. Lin, and C. A. Bradfield
Resistance to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicity and Abnormal Liver Development in Mice Carrying a Mutation in the Nuclear Localization Sequence of the Aryl Hydrocarbon Receptor
J. Biol. Chem.,
May 9, 2003;
278(20):
17767 - 17774.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. R. Mattingly, R. A. Gibbs, R. E. Menard, and J. J. Reiners Jr.
Potent Suppression of Proliferation of A10 Vascular Smooth Muscle Cells by Combined Treatment with Lovastatin and 3-Allylfarnesol, an Inhibitor of Protein Farnesyltransferase
J. Pharmacol. Exp. Ther.,
October 1, 2002;
303(1):
74 - 81.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Seubert, A. J. Darmon, A. O. S. El-Kadi, S. J. A. D'Souza, and J. R. Bend
Apoptosis in Murine Hepatoma Hepa 1c1c7 Wild-Type, C12, and C4 Cells Mediated by Bilirubin
Mol. Pharmacol.,
August 1, 2002;
62(2):
257 - 264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Santini, S. Myrand, C. Elferink, and J. J. Reiners Jr.
Regulation of Cyp1a1 Induction by Dioxin as a Function of Cell Cycle Phase
J. Pharmacol. Exp. Ther.,
November 1, 2001;
299(2):
718 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Kessel, J. A. Caruso, and J. J. Reiners Jr.
Potentiation of Photodynamic Therapy by Ursodeoxycholic Acid
Cancer Res.,
December 1, 2000;
60(24):
6985 - 6988.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
B. PAIGEN, N. J. SCHORK, K. L. SVENSON, Y.-C. CHEAH, J.-L. MU, F. LAMMERT, D. Q.-H. WANG, G. BOUCHARD, and M. C. CAREY
Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice
Physiol Genomics,
November 9, 2000;
4(1):
59 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Quadri, A. N. Qadri, M. E. Hahn, K. K. Mann, and D. H. Sherr
The Bioflavonoid Galangin Blocks Aryl Hydrocarbon Receptor Activation and Polycyclic Aromatic Hydrocarbon-Induced Pre-B Cell Apoptosis
Mol. Pharmacol.,
September 1, 2000;
58(3):
515 - 525.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Q. Ma, A. J. Renzelli, K. T. Baldwin, and J. M. Antonini
Superinduction of CYP1A1 Gene Expression. REGULATION OF 2,3,7,8-TETRACHLORODIBENZO-p-DIOXIN-INDUCED DEGRADATION OF Ah RECEPTOR BY CYCLOHEXIMIDE
J. Biol. Chem.,
April 21, 2000;
275(17):
12676 - 12683.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Ma and K. T. Baldwin
2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced Degradation of Aryl Hydrocarbon Receptor (AhR) by the Ubiquitin-Proteasome Pathway. ROLE OF THE TRANSCRIPTION ACTIVATON AND DNA BINDING OF AhR
J. Biol. Chem.,
March 17, 2000;
275(12):
8432 - 8438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Puga, S. J. Barnes, T. P. Dalton, C.-y. Chang, E. S. Knudsen, and M. A. Maier
Aromatic Hydrocarbon Receptor Interaction with the Retinoblastoma Protein Potentiates Repression of E2F-dependent Transcription and Cell Cycle Arrest
J. Biol. Chem.,
January 28, 2000;
275(4):
2943 - 2950.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|